ICICI Direct's research report on Shankara Building Products
Shankara Building Products’ (Shankara) H1FY21 has been about balance sheet repair and cost rationalisation amid the Covid-19 shock. For H1FY21, the topline de-grew 34% YoY to Rs 834 crore (decline of ~23% YoY for Q2, with a sharp sequential improvement) impacted by Covid-19. The EBITDA margin for H1FY21 declined 350 bps YoY to 1% (down 20 bps to 3.8% in Q2) mainly on account of negative operating leverage. Reported loss was at Rs 19 crore for H1 while PAT for Q2 was at Rs 6.3 crore, down 39% YoY.
Outlook
Hence, we maintain HOLD with a target price of Rs 320/share. We value its retail business at Rs 310/share (6x FY22E EV/EBIT).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!